Palvella Therapeutics (PVLA) Cash from Operations (2013 - 2026)
Palvella Therapeutics (PVLA) reported Cash from Operations of 10900000.0 for Q1 2026, down 61.05% year-over-year from 27986039.45 in Q1 2025, and down 121.54% on a QoQ basis from 4920000.0 in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Cash from Operations data on file, last reported at 10900000.0 in Q1 2026.
- Quarterly Cash from Operations fell 61.05% year-over-year to 10900000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29132000.0 (down 76.49% YoY) and the FY2025 annual result came in at 25000000.0, down 130.63% from the prior year.
- Cash from Operations retreated to 10900000.0 in Q1 2026 per PVLA's latest filing, from 4920000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20447000.0 in Q4 2023 and bottomed at 22643000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 7880000.0 (2025), against an average of 7080882.35.
- The widest annual swing landed in 2023, when Cash from Operations jumped 258.1%; it then tumbled 514.16% in 2025.
- Tracing PVLA's Cash from Operations over 5 years: stood at 12933000.0 in 2022, then jumped by 258.1% to 20447000.0 in 2023, then slumped by 126.38% to 5393000.0 in 2024, then gained by 8.77% to 4920000.0 in 2025, then tumbled by 121.54% to 10900000.0 in 2026.
- Per Business Quant, the three latest PVLA Cash from Operations figures stand at 10900000.0 (Q1 2026), 4920000.0 (Q4 2025), and 7880000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | -10.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.90 Mn |
| Mar 31, 2026 | -10.90 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -5.43 Mn |
| Jun 30, 2025 | -5.43 Mn |
| Mar 31, 2025 | -6.77 Mn |
| Mar 31, 2025 | -6.77 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | -2.74 Mn |
| Sep 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 20.45 Mn |
| Dec 31, 2023 | 20.45 Mn |
| Sep 30, 2023 | -9.72 Mn |
| Sep 30, 2023 | -9.72 Mn |
| Jun 30, 2023 | -13.43 Mn |
| Jun 30, 2023 | -13.43 Mn |
| Mar 31, 2023 | -11.00 Mn |
| Mar 31, 2023 | -11.00 Mn |
| Dec 31, 2022 | -12.93 Mn |
| Dec 31, 2022 | -12.93 Mn |
| Sep 30, 2022 | -8.78 Mn |
| Sep 30, 2022 | -8.78 Mn |
| Jun 30, 2022 | -15.58 Mn |
| Jun 30, 2022 | -15.58 Mn |
| Mar 31, 2022 | -22.64 Mn |
| Mar 31, 2022 | -22.64 Mn |
| Dec 31, 2021 | -10.94 Mn |
| Dec 31, 2021 | -10.94 Mn |
| Sep 30, 2021 | -14.48 Mn |
| Sep 30, 2021 | -14.48 Mn |
| Jun 30, 2021 | 29.91 Mn |
| Jun 30, 2021 | 29.91 Mn |
| Mar 31, 2021 | -12.14 Mn |
| Mar 31, 2021 | -12.14 Mn |
| Dec 31, 2020 | -13.42 Mn |
| Dec 31, 2020 | -13.42 Mn |
| Sep 30, 2020 | -7.57 Mn |
| Sep 30, 2020 | -7.57 Mn |
| Jun 30, 2020 | -9.78 Mn |
| Jun 30, 2020 | -9.78 Mn |
| Mar 31, 2020 | -15.13 Mn |
| Mar 31, 2020 | -15.13 Mn |
| Dec 31, 2019 | -13.97 Mn |
| Dec 31, 2019 | -13.97 Mn |
| Sep 30, 2019 | -12.65 Mn |
| Sep 30, 2019 | -12.65 Mn |
| Jun 30, 2019 | -10.73 Mn |
| Jun 30, 2019 | -10.73 Mn |
| Mar 31, 2019 | -15.11 Mn |
| Mar 31, 2019 | -15.11 Mn |
| Dec 31, 2018 | -9.06 Mn |
| Dec 31, 2018 | -9.06 Mn |
| Sep 30, 2018 | -14.36 Mn |
| Sep 30, 2018 | -14.36 Mn |
| Jun 30, 2018 | -8.99 Mn |
| Jun 30, 2018 | -8.99 Mn |
| Mar 31, 2018 | 31.34 Mn |
| Mar 31, 2018 | 31.34 Mn |
| Dec 31, 2017 | -4.69 Mn |
| Dec 31, 2017 | -4.69 Mn |
| Sep 30, 2017 | 35.20 Mn |
| Sep 30, 2017 | 35.20 Mn |
| Jun 30, 2017 | -6.52 Mn |
| Jun 30, 2017 | -6.52 Mn |
| Mar 31, 2017 | 25.77 Mn |
| Mar 31, 2017 | 25.77 Mn |
| Dec 31, 2016 | -6.73 Mn |
| Dec 31, 2016 | -6.73 Mn |
| Sep 30, 2016 | -3.58 Mn |
| Sep 30, 2016 | -3.58 Mn |
| Jun 30, 2016 | -6.11 Mn |
| Jun 30, 2016 | -6.11 Mn |
| Mar 31, 2016 | 2.03 Mn |
| Mar 31, 2016 | 2.03 Mn |
| Dec 31, 2015 | -2.49 Mn |
| Dec 31, 2015 | -2.49 Mn |
| Sep 30, 2015 | -3.54 Mn |
| Sep 30, 2015 | -3.54 Mn |
| Jun 30, 2015 | -3.08 Mn |
| Jun 30, 2015 | -3.08 Mn |
| Mar 31, 2015 | -3.59 Mn |
| Mar 31, 2015 | -3.59 Mn |
| Sep 30, 2014 | -13,918.00 |
| Sep 30, 2014 | -13,918.00 |
| Jun 30, 2014 | -3.41 Mn |
| Jun 30, 2014 | -3.41 Mn |
| Mar 31, 2014 | -418,477.00 |
| Mar 31, 2014 | -418,477.00 |
| Dec 31, 2013 | -948.00 |
| Dec 31, 2013 | -948.00 |
| Sep 30, 2013 | -4,512.00 |
| Sep 30, 2013 | -4,512.00 |
| Jun 30, 2013 | -274.00 |
| Jun 30, 2013 | -274.00 |